Workshop programme

Monday 23 May

15:45-16:30

Atherothrombosis and myeloid cells

Chair:
  • Lina Badimon
  • Marianne Benn
Detailing the role of neutrophils in atherothrombosis
Irene Lang, Vienna, Austria
Platelet activation and inhibition in atherothrombosis and inflammation
Michael Potente, Germany
11:00-12:30

Environment and cardiovascular risk

Chair:
  • Dan Gaita
  • Jeanine Roeters Van Lennep
Dietary components and patterns as determinants of cardiovascular risk
Alice Lichtenstein, Boston, USA
Environment
Thomas Münzel, Germany
Exercise and cardiovascular disease in 2022: When, who and how?
Patrick Schrauwen, Maastricht, The Netherlands
15:45-17:15

Modulating immune responses in atherosclerosis

Chair:
  • Christoph Binder
  • Gerald Pasterkamp
Macrophage plasticity in atherosclerotic plaques
Claudia Monaco, Oxford, UK
Modulating T cell immunity in ASCVD
Ziad Mallat, UK
11:00-12:30

Non-classical risk factors: Transitioning from association to causality

Chair:
  • Christoph Binder
  • Giulia Chiesa
Extracellular vesicles in CVD
Felix Jansen, Germany
Systems biology to estimate cardiovascular risk
Manual Mayr, London, UK
11:00-12:30

PCSK9 – new insights

Chair:
  • Marat Ezhov
  • Winfried Märtz
Deciphering PCSK9 function in the intestine
Bertrand Cariou, Nantes, France
The role of PCSK9 in myocardial lipid metabolism and cardiac biology
Danilo Norata, Milano, Italy

Tuesday 24 May

11:00-11:45

Apo B containing lipoproteins

Chair:
  • Marcello Arca
  • Katariina Öörni
Intracellular regulation of lipoprotein receptors
Bart van de Sluis, Groningen, The Netherlands
LDL disposal: Receptor vs non-receptor
Marina Cuchel, Philadelphia, USA
15:45-17:15

Cardiometabolic Risk and Ectopic Fat

Chair:
  • Alberto Mello e Silva
  • Philippe Moulin
Diabetes care: Changing the focus from treat to target to treat to benefit
Giorgio Sesti, Roma, Italy
Does the location of ectopic fat matter for CVD risk
Michael Roden, Düsseldorf, Germany
15:45-17:15

Endothelial cell biology in atherosclerosis

Chair:
  • Lina Badimon
  • Paolo Parini
Cell metabolism in endothelial cells
Carlo Patrono, Roma, Italy
Genome-wide regulation of microRNAs in endothelial cells
Minna Kaikkonen-Maatta, Kuopio, Finland
11:00-12:30

Smooth muscle cell biology and plaque stability

Chair:
  • Esther Lutgens
  • Gerald Pasterkamp
Smooth muscle cells plasticity in plaque stability
Marie-Luce Bochaton-Piallat, Geneva, Switzerland
The role of necroptosis in atherogenesis and plaque stability
Katey Rayner, Ottawa, Canada

Wednesday 25 May

11:00-11:45

Aging, dementia and stroke

Chair:
  • Ruth Frikke-Schmidt
  • Alexandros Tselepis
Cell senescence in atherosclerosis and vascular ageing
Martin Bennett, Cambridge, United Kingdom
Clonal hematopoiesis affecting cardiovascular health
Jose Javier Fuster, Madrid, Spain
11:00-11:45

Imaging guided management

Chair:
  • Ulf Landmesser
  • Oner Ozdogan
Imaging for plaque progression
Steve Nicholls, Melbourne, Australia
Imaging guided prevention: Hype or real?
Michael Blaha, Baltimore, USA
11:00-12:30

New World of targeted therapies (targets, delivery systems,new molecules)

Chair:
  • Franco Bernini
  • Nathan Wong
Cell based therapies in atherosclerosis
Megan Levings, Canada
Leveraging on genetics to identify new targets
Sekar Kathiresan, Cambridge, USA